Navigation Links
Keystone Symposia announces grant from Alfred P. Sloan Foundation
Date:4/16/2013

Keystone Symposia on Molecular and Cellular Biology is pleased to announce it has received a grant from the Alfred P. Sloan Foundation for a unique Advanced Life Sciences Training Program.

The grant will provide funding for a two-day conference in Denver in July 2013 for all five classes of participants in the Keystone Symposia Fellows Program since its inception in 2008. The Fellows Program is a high-level life science research mentoring and positioning program for postdoctoral fellows and other early-career investigators committed to diversity. Through involvement in the Keystone Symposia program development process, Fellows receive invaluable mentoring and access to the inner workings of the life sciences community. To date, 18 individuals have graduated from the Program, which is funded by a multi-year MARC (Minority Access to Research Careers) grant from the National Institute of General Medical Sciences of the NIH. Five participants are currently mid-way through the 2012-2013 Program.

The summer training conference will provide a face-to-face opportunity equipping participants with advanced grant-writing skills to increase the rate of grant acquisition for early-career scientists. It will also provide them with strategies and tools to confront diversity-related challenges and issues in the workplace. A variety of experts will be tapped from around the country to provide the training.

Dr. Laina King, Director of Diversity in Life Science Programs at Keystone Symposia, expressed her appreciation for the grant: "The support from the Foundation allows us to take the Fellows Program one step further and give participants formal and focused training in the areas that are proving most challenging for early-career investigators. We are deeply grateful for the commitment the Alfred P. Sloan Foundation is demonstrating to life science diversity in making such a program possible."

Dr. Elizabeth Boylan, Program Director at the Alfred P. Sloan Foundation, commented: "I am very pleased that we were able to make this grant as part of our higher-education portfolio focusing on professional advancement for underrepresented populations. We value the opportunity to assist early-career scientists in the acquisition of key professional skills, and look forward to learning about outcomes vis--vis standard career parameters as well as engagement with diversity matters on their home campuses and in their professional societies."

This is the second grant for Keystone Symposia from the Alfred P. Sloan Foundation. Some of Keystone Symposia's earliest diversity initiatives were launched with the help of a Sloan grant received in April 2008. Subsequent efforts have been funded with the help of the MARC grant as well as corporate support from Amgen, Biogen Idec and Novartis Institutes for BioMedical Research.


'/>"/>

Contact: Yvonne Psaila
yvonnep@keystonesymposia.org
970-262-2676
Keystone Symposia on Molecular & Cellular Biology
Source:Eurekalert

Related biology news :

1. Entomology 2012 to present 105 insect symposia in November
2. BiOptix to highlight new 404pi instrument at European symposia
3. Modern Mobility Aids, Inc. Announces a Revised Agreement for the Acquisition of Lumigene
4. ChromaDex® Announces Financial Results for the Year Ended 2011
5. Improved Authentication and Confidentiality Protection. ICAP Patent Brokerage Announces for Auction Important Patents in Data Encryption and Document Security
6. FirstMark Announces New Hire Jay Houtman as Southeast Regional Sales Manager
7. Global Information Inc. Announces Discounted Conference Registration For Bio-IT World Asia and Biodetection Technologies 2012
8. Virginia Tech announces 2012 football helmet ratings; 2 more added to the 5-star mark
9. Medbox, Inc. Announces Top-Tier Rating by Dun & Bradstreet Credibility Corporation
10. BioLife Solutions Announces 7th Consecutive Quarter of Record Revenue
11. Mass. Eye and Ear announces Curing Kids Fund grant recipients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/15/2016)... Research and Markets has announced ... 2016-2020,"  report to their offering.  , ... global gait biometrics market is expected to grow ... 2016-2020. Gait analysis generates multiple variables ... to compute factors that are not or cannot ...
(Date:3/31/2016)... , March 31, 2016   ... ("LegacyXChange" or the "Company") LegacyXChange is excited ... of its soon to be launched online site for ... https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also provide potential shareholders a ... DNA technology to an industry that is notorious for ...
(Date:3/23/2016)... WAKEFIELD, Massachusetts , March 23, 2016 ... kombiniert im Interesse erhöhter Sicherheit Gesichts- und ... Xura, Inc. (NASDAQ: MESG ... heute bekannt, dass das Unternehmen mit SpeechPro ... insbesondere aus der Finanzdienstleistungsbranche, wird die Möglichkeit ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... June 27, 2016  Liquid Biotech ... funding of a Sponsored Research Agreement with The ... cells (CTCs) from cancer patients.  The funding will ... levels correlate with clinical outcomes in cancer patients ... will then be employed to support the design ...
(Date:6/24/2016)... , June 24, 2016 Epic ... sensitively detects cancers susceptible to PARP inhibitors by ... tumor cells (CTCs). The new test has already ... therapeutics in multiple cancer types. Over ... DNA damage response pathways, including PARP, ATM, ATR, ...
(Date:6/23/2016)... ... 23, 2016 , ... Mosio, a leader in clinical research ... Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the ... tools, and strategies for clinical researchers. , “The landscape of how patients receive ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
Breaking Biology Technology: